Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Mike McElhaugh is recorded as CEO and COO at Arbutus Biopharma Corp (ABUS). Arbutus Biopharma Corp reported in an 8-K filed October 24, 2022 that Mike McElhaugh was appointed Chief Operating Officer, effective November 1, 2022. Mike McElhaugh has spoken on 1 earnings call across 1 company, most recently for Arbutus Biopharma Corp on May 2, 2024.
“On October 18, 2022, the Board of Directors (the "Board") of Arbutus Biopharma Corporation (the "Company") appointed Mike McElhaugh, age 48, as the Company's Chief Operating Officer, effective as of November 1, 2022 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-11-01–present
Recorded roles and call appearances connecting this person to public companies.
CEO, COO
2022-11-01–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
